{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:4594",
      "entity_text" : "result",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:Q8IVS2",
      "entity_text" : "MT",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Taxol, an effective anti-cancer drug widely being used in clinic, is a well established antineoplastic agent that binds specifically to the beta-tubulin subunit of microtubules (MT) to arrest mitosis and result in programmed cell death (i.e., apoptosis) and has shown remarkable activity in the treatment of breast, lung, ovarian, bladder and head and neck cancers XREF_BIBR.",
  "reading_complete" : "2020-08-03T15:19:17Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T15:17:55Z",
  "trigger" : "arrest",
  "evidence" : [ "MT) to arrest mitosis and result" ],
  "pmc_id" : "3287425",
  "score" : 0
}